Enzo Biochem (ENZ) Appoints Steven J. Pully to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
October 30, 2023 4:15 PM EDTFARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Â Enzo Biochem, Inc. (NYSE: ENZ) (Enzo or the Company), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Companys Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well.
In 2023, Enzo completed the divestiture of Enzo Clinical Labs, Inc. and focused its strategy on growing the life sciences division, said Kara Cannon, Enzos Chief Executive Officer. Steve brings a unique portfolio of legal, corporate governance, and financial... More



